Total Payments
$3,683
2024 Payments
$626.41
Companies
33
Transactions
186
Medicare Patients
862
Medicare Billing
$68,367
Payment Breakdown by Category
Food & Beverage$3,583 (97.3%)
Education$99.99 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,583 | 185 | 97.3% |
| Education | $99.99 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $596.08 | 48 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $451.10 | 20 | $0 (2024) |
| Alkermes, Inc. | $348.50 | 18 | $0 (2024) |
| Lilly USA, LLC | $339.85 | 16 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $330.36 | 9 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $211.30 | 4 | $0 (2024) |
| ABBVIE INC. | $201.06 | 10 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $149.93 | 7 | $0 (2024) |
| Almatica Pharma LLC | $106.88 | 4 | $0 (2024) |
| Corium, LLC | $106.70 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $626.41 | 23 | Supernus Pharmaceuticals, Inc. ($184.29) |
| 2023 | $1,104 | 56 | Teva Pharmaceuticals USA, Inc. ($297.41) |
| 2022 | $468.21 | 30 | Novartis Pharmaceuticals Corporation ($178.17) |
| 2021 | $1,484 | 77 | Novartis Pharmaceuticals Corporation ($404.13) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: CNS | ||||||
| 07/13/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: ANTI-ANXIETY | ||||||
| 07/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: CNS | ||||||
| 06/01/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: ADHD | ||||||
| 05/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: CNS | ||||||
| 05/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Central Nervous System | ||||||
| 04/19/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: CNS | ||||||
| 04/13/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: ANTI-ANXIETY | ||||||
| 04/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $38.83 | General |
| Category: Central Nervous System | ||||||
| 04/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 03/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: CNS | ||||||
| 03/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: CNS | ||||||
| 03/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Central Nervous System | ||||||
| 02/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Central Nervous System | ||||||
| 02/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $40.28 | General |
| Category: Central Nervous System | ||||||
| 01/19/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $132.76 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: CNS | ||||||
| 01/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: CNS | ||||||
| 01/12/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $14.36 | General |
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 117 | 216 | $28,962 | $8,615 |
| 2021 | 10 | 383 | 802 | $99,475 | $32,011 |
| 2020 | 10 | 362 | 623 | $87,850 | $27,741 |
Total Patients
862
Total Services
1,641
Medicare Billing
$68,367
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 44 | $6,582 | $3,165 | 48.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 13 | 17 | $4,250 | $1,502 | 35.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 18 | 19 | $5,700 | $1,156 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $2,580 | $1,111 | 43.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 14 | 15 | $2,250 | $612.04 | 27.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,750 | $567.75 | 20.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 12 | 97 | $4,850 | $502.05 | 10.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 144 | $21,600 | $10,025 | 46.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 48 | $9,600 | $4,795 | 49.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 59 | 82 | $12,300 | $3,372 | 27.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 41 | 44 | $13,200 | $3,273 | 24.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 29 | 34 | $8,500 | $3,164 | 37.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $8,250 | $2,935 | 35.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 47 | 372 | $18,600 | $1,948 | 10.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 17 | 20 | $4,000 | $1,132 | 28.3% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2021 | 12 | 13 | $2,300 | $945.46 | 41.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,125 | $422.04 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 90 | 140 | $19,650 | $8,055 | 41.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 45 | $8,750 | $3,760 | 43.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 45 | 51 | $15,300 | $3,608 | 23.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 39 | 39 | $8,950 | $2,992 | 33.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 29 | 33 | $8,250 | $2,879 | 34.9% |
| 17000 | Destruction of skin growth | Office | 2020 | 44 | 57 | $8,550 | $2,471 | 28.9% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 13 | 14 | $4,200 | $1,755 | 41.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 35 | 212 | $10,600 | $1,052 | 9.9% |
About Efstratia Rabinowitz
Efstratia Rabinowitz is a Physician Assistant healthcare provider based in Astoria, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2010. The National Provider Identifier (NPI) number assigned to this provider is 1184934705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Efstratia Rabinowitz has received a total of $3,683 in payments from pharmaceutical and medical device companies, with $626.41 received in 2024. These payments were reported across 186 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,583).
As a Medicare-enrolled provider, Rabinowitz has provided services to 862 Medicare beneficiaries, totaling 1,641 services with total Medicare billing of $68,367. Data is available for 3 years (2020–2022), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Astoria, NY
- Active Since 10/16/2010
- Last Updated 08/17/2017
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184934705
Products in Payments
- COSENTYX (Biological) $557.88
- TALTZ (Drug) $339.85
- ARISTADA (Drug) $299.44
- Austedo XR (Drug) $233.76
- AUSTEDO (Drug) $217.34
- Qelbree (Drug) $184.29
- Ilumya (Biological) $158.12
- TRINTELLIX (Drug) $149.93
- SKYRIZI (Biological) $131.93
- Azstarys (Drug) $106.70
- Cimzia (Drug) $96.44
- Seysara (Drug) $80.24
- ABILIFY MAINTENA (Drug) $72.05
- ADBRY (Biological) $69.84
- LOREEV XR (Drug) $60.70
- CAPLYTA (Drug) $59.17
- Absorica LD (Drug) $54.63
- DUPIXENT (Biological) $53.96
- SPRAVATO (Drug) $52.88
- VRAYLAR (Drug) $52.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Astoria
Bin Bin Fan
Physician Assistant — Payments: $6,194
Physician Assistant $6,194
Kendel Bennett
Physician Assistant — Payments: $4,462
Physician Assistant $4,462
Vincent Deleon, Pa, PA
Physician Assistant — Payments: $3,456
Physician Assistant $3,456
Gabriella Dutsar, Pa, PA
Physician Assistant — Payments: $3,425
Physician Assistant $3,425
Elvira Khaimov, Pa-C, PA-C
Physician Assistant — Payments: $1,735
Physician Assistant $1,735
Miss. Tara Halpern, Pa, PA
Physician Assistant — Payments: $1,448
Physician Assistant $1,448